ECT augmentation of antipsychotics in severely ill schizophrenia: a naturalistic, observational study.

International Journal of Psychiatry in Clinical Practice
Nazife Gamze Usta SaglamIbrahim Balcioglu

Abstract

There is positive evidence to support the role of electroconvulsive therapy (ECT) in the treatment of schizophrenia; however, it is unclear to what extent this growing evidence reflects the actual situation in clinical practice. The aim of this study was to explore the efficacy of ECT augmentation to antipsychotics in individuals with schizophrenia in a naturalistic-observational environment. Eighty-one patients diagnosed with schizophrenia, hospitalised due to acute psychotic exacerbation were included in the study. We compared changes in Positive and Negative Symptom Rating Scale (PANSS) scores between patients treated only with APs and those in the ECT augmentation group. A statistically significant decrease in symptom severity was observed in all PANSS subscales in both groups. In the ECT group, 95% of the patients (n = 39) responded to treatment compared to 75% of the non-ECT group (n = 30) (χ2=6.496, df = 1, p = 0.011). We found that combining ECT with AP significantly increased treatment response, which was defined as at least 25% PANSS symptom reduction, in patients with acute exacerbation of schizophrenia, compared to AP alone. Augmentation of ECT seems to increase responsiveness during acute treatment of severely ill ...Continue Reading

References

Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Feb 22, 2000·Clinical Neuropharmacology·M KupchikM Kotler
Aug 31, 2001·The Journal of ECT·W Chanpattana, M L Chakrabhand
Nov 13, 2004·European Archives of Psychiatry and Clinical Neuroscience·K H KhoD H Linszen
Jul 25, 2006·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Caroline NothdurfterThomas C Baghai
Dec 18, 2008·Pakistan Journal of Biological Sciences : PJBS·A Masoudzadeh, A R Khalilian
Jun 27, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·H Hustig, R Onilov
Nov 6, 2009·Schizophrenia Bulletin·Michael ObermeierMichael Riedel
Apr 2, 2010·Schizophrenia Bulletin·Stefan LeuchtJohn M Davis
Dec 7, 2010·European Archives of Psychiatry and Clinical Neuroscience·Diana KristensenMartin Balslev Jørgensen
Mar 19, 2013·Schizophrenia Research·Maurizio PompiliPaolo Girardi
May 9, 2014·The Journal of ECT·Peter B RosenquistAnilkumar Pillai
May 14, 2014·The Journal of ECT·Pia BaldingerRupert Lanzenberger
Aug 27, 2014·The American Journal of Psychiatry·Georgios PetridesAlan Mendelowitz
May 25, 2016·The Psychiatric Clinics of North America·Helio Elkis, Peter F Buckley
Jun 17, 2016·European Psychiatry : the Journal of the Association of European Psychiatrists·J LiJ Wang
Mar 16, 2017·The Journal of Clinical Psychiatry·Tyler S KasterDaniel M Blumberger
Mar 13, 2018·Current Opinion in Psychiatry·Sohag N SanghaniCharles H Kellner
Jun 14, 2019·Molecular Neuropsychiatry·Sana A AliRaphael J Braga

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Convulsive Therapy
Lothar B. Kalinowsky
The Journal of Mental Science
A A BAKERJ G THORPE
Indian Journal of Psychiatry
H D Chopra
© 2022 Meta ULC. All rights reserved